Kyle Armbrester
Kyle Armbrester became the Chief Executive Officer of Datavant on May 2, 2024, after joining its Board of Directors in October 2023. As CEO, he is focused on accelerating the product roadmap, investing in technology and artificial intelligence, and building a data fabric to enhance the secure and accessible use of health data. Under his leadership, Datavant aims to connect the world's health data, enabling the movement of over 60 million healthcare records among thousands of organizations.
Career Milestones
- Became CEO of Datavant in May 2024, leading the company’s mission to connect and make health data safe and usable.
- Joined Datavant’s Board of Directors in October 2023, prior to assuming the CEO role.
- Previously served as CEO of Signify Health, where he guided the company through a successful IPO in February 2021 and its acquisition by CVS Health in March 2023.
- Held the position of Chief Product Officer at Athenahealth, contributing to revenue growth over seven years and launching the company’s partnership marketplace.
- Served on the CVS Health management team for 1.5 years, focusing on healthcare delivery strategy.
- Recognized for leveraging technology, AI, and data integration to advance healthcare innovation and improve data connectivity across the industry.
About Datavant
Datavant is a trusted health data collaboration platform that makes health data secure, accessible, and actionable for payers, providers, life sciences, legal, and insurance clients globally. The company's differentiator lies in its commitment to customer trust, innovation, and maintaining the largest health data exchange in the U.S., ensuring patient privacy and data security.